| Audit Diagnostics has been developing and manufacturing clinical diagnostic reagents and healthcare products since 1993. In 2006, Audit Diagnostics moved to its custom built, state of the art manufacturing facility, incorporating the latest production technologies including complete clean room environment to the highest GMP standards. Through its network of Distributors and OEM partners in over 100 countries worldwide, Audit Diagnostics provides its range of Clinical Chemistry, Immunoassays, DOA, TDM, and Diagnostic Reagents together with the Sapphire® range of Clinical Chemistry Analysers ranging from semi-automated through to 350 tests and 600 tests per hour Fully Automated Random access analysers. The recent introduction of Rapid Test together with the SterlSTAT range of unique decontamination products further enhances the product range. In 2007 Audit Diagnostics launched the world''s first complete Wet Chemistry Point of Care (P.O.C.T.) clinical chemistry system. This unique patented system will allow for full diagnostic analysis of Clinical Chemistry DOA, TDM, Immunoassay at near patient point of care outlets such as doctors'' offices, emergency clinics, neo-natal units, veterinary laboratories, satellite laboratories, providing quality results totally compatible with the central laboratory chemistry analysers. Audit Diagnostics will also launch its Sapphire XT® TDM and DOA fully automated analyser. Through its dedicated R&D teams Audit Diagnostics will continue to introduce unique and improved chemistries, including Midi-Chip technologies and further quantitative Point of Care systems. |
